154 related articles for article (PubMed ID: 20497425)
1. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of butyrate analogues in HT-29 cancer cells.
Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells.
Fung KY; Ooi CC; Lewanowitsch T; Tan S; Tan HT; Lim TK; Lin Q; Williams DB; Lockett TJ; Cosgrove LJ; Chung MC; Head RJ
J Proteome Res; 2012 Dec; 11(12):6019-29. PubMed ID: 23057685
[TBL] [Abstract][Full Text] [Related]
4. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase.
Lea MA; Tulsyan N
Anticancer Res; 1995; 15(3):879-83. PubMed ID: 7645975
[TBL] [Abstract][Full Text] [Related]
5. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
6. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf.
Wagner S; Roemer K
Biochem Pharmacol; 2005 Apr; 69(7):1059-67. PubMed ID: 15763542
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
Frønsdal K; Saatcioglu F
Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
[TBL] [Abstract][Full Text] [Related]
9. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response.
Fung KY; Brierley GV; Henderson S; Hoffmann P; McColl SR; Lockett T; Head R; Cosgrove L
J Proteome Res; 2011 Apr; 10(4):1860-9. PubMed ID: 21235278
[TBL] [Abstract][Full Text] [Related]
10. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
Chen J; Du C; Kang J; Wang J
Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells.
Fung KY; Lewanowitsch T; Henderson ST; Priebe I; Hoffmann P; McColl SR; Lockett T; Head R; Cosgrove LJ
J Proteome Res; 2009 Mar; 8(3):1220-7. PubMed ID: 19195990
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
[TBL] [Abstract][Full Text] [Related]
14. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.
Thangaraju M; Carswell KN; Prasad PD; Ganapathy V
Biochem J; 2009 Jan; 417(1):379-89. PubMed ID: 18789002
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon.
Waldecker M; Kautenburger T; Daumann H; Busch C; Schrenk D
J Nutr Biochem; 2008 Sep; 19(9):587-93. PubMed ID: 18061431
[TBL] [Abstract][Full Text] [Related]
16. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
Spurling CC; Godman CA; Noonan EJ; Rasmussen TP; Rosenberg DW; Giardina C
Mol Carcinog; 2008 Feb; 47(2):137-47. PubMed ID: 17849419
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
18. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
19. tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.
Valente S; Trisciuoglio D; Tardugno M; Benedetti R; Labella D; Secci D; Mercurio C; Boggio R; Tomassi S; Di Maro S; Novellino E; Altucci L; Del Bufalo D; Mai A; Cosconati S
ChemMedChem; 2013 May; 8(5):800-11. PubMed ID: 23526814
[TBL] [Abstract][Full Text] [Related]
20. In vitro studies on the inhibition of colon cancer by butyrate and carnitine.
Roy MJ; Dionne S; Marx G; Qureshi I; Sarma D; Levy E; Seidman EG
Nutrition; 2009; 25(11-12):1193-201. PubMed ID: 19619983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
